Surfactant function in neonates with respiratory distress syndrome

被引:7
|
作者
Griese, M [1 ]
Westerburg, B [1 ]
机构
[1] Ludwigs Maximillian Univ, Kinderpoliklin, Lung Res Grp, D-80336 Munich, Germany
关键词
surfactant phospholipids; pulsating bubble surfactometer; protein leakage; inhibition; sequential small-volume lavage; premature infants; very low birth weight; respiratory distress syndrome;
D O I
10.1159/000029245
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) who suffered from severe respiratory distress syndrome (RDS) and who had received exogenous bovine lipid extracted surfactant on the first day of life was compared to that in a second group of 8 neonates (birth weight 940 +/- 110 g) with mild RDS who had not received surfactant treatment. Mechanical respiratory support from day 2 on was the same in both groups. The minimal surface tension (gamma(min)) improved steadily, falling from about 30 mN/m initially to less than 20 mN/m before extubation, A consistent but loose correlation was found between gamma(min) and mechanical respiratory support necessary, as quantitated by the oxygenation index. Total protein was about 0.8 +/- 0.2 mg/mg of phospholipids and did not change during the first week of life. There were no correlations between total protein and gamma(min) or the oxygenation index. The data suggest that inhibition of surfactant function by proteins leaked into the airspaces does not play a major role during recovery from RDS, Instead, endogenous remodelling of surfactant might be of greater relevance.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [1] Surfactant replacement therapy beyond respiratory distress syndrome in neonates
    Jasani, Bonny
    Kabra, Nandkishor
    Nanavati, Ruchi
    [J]. INDIAN PEDIATRICS, 2016, 53 (03) : 229 - 234
  • [2] Surfactant replacement therapy beyond respiratory distress syndrome in neonates
    Bonny Jasani
    Nandkishor Kabra
    Ruchi Nanavati
    [J]. Indian Pediatrics, 2016, 53 : 229 - 234
  • [3] THE FATE OF EXOGENOUS SURFACTANT IN NEONATES WITH RESPIRATORY-DISTRESS SYNDROME
    HALLMAN, M
    MERRITT, TA
    BRY, K
    [J]. CLINICAL PHARMACOKINETICS, 1994, 26 (03) : 215 - 232
  • [4] SURFACTANT FUNCTION IN RESPIRATORY-DISTRESS SYNDROME
    IKEGAMI, M
    JACOBS, H
    JOBE, A
    [J]. JOURNAL OF PEDIATRICS, 1983, 102 (03): : 443 - 447
  • [5] Treatment of acute respiratory distress syndrome in secondary surfactant deficiency in neonates
    Samudro, Heru
    Winarno
    [J]. PAEDIATRICA INDONESIANA, 2007, 47 (06) : 303 - 306
  • [6] Surfactant status in preterm Neonates recovering from respiratory distress syndrome
    Verlato, Giovanna
    Cogo, Paola Elisa
    Balzani, Marco
    Gucciardi, Antonina
    Burattini, Ilaria
    De Benedictis, Fernando
    Martiri, Giovanna
    Carnielli, Virgilio Paolo
    [J]. PEDIATRICS, 2008, 122 (01) : 102 - 108
  • [7] Association of surfactant protein B haplotypes with respiratory distress syndrome in neonates
    Silvia, Smolarova
    Zora, Lasabova
    Veronika, Holubekova
    Pavol, Lukac
    Maria, Skerenova
    Katarina, Matasova
    Mirko, Zibolen
    Andrea, Calkovska
    [J]. ACTA PHYSIOLOGICA, 2015, 215 : 34 - 34
  • [8] Does nebulised surfactant benefit neonates with respiratory distress syndrome on noninvasive respiratory support?
    Chawla, Deepak
    [J]. ACTA PAEDIATRICA, 2019, 108 (04) : 775 - 775
  • [9] Surfactant and respiratory distress syndrome
    Milner, AD
    [J]. TURKISH JOURNAL OF PEDIATRICS, 1996, 38 (01) : 37 - 43
  • [10] Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates
    Jiang, ZQ
    Sun, GM
    Ma, YM
    [J]. ACTA PHARMACOLOGICA SINICA, 1997, 18 (02): : 182 - 184